×
Best Practices has moved to a work-at-home response to support the safety of our employees, clients and home communities. We are serving all clients and partners through our Video Meetings TelePlatform as well as through our existing research, support and communication channels. Please reach out as you have business needs or require insight to inform your operations and decisions in this unusual time through which we are all navigating. We are cheering for your safety and wellbeing. We are here to support you.

Note: Data in this study are segmented to present views for Total Benchmark Class and Diabetes respondents.

Study Overview

Effective payer education of new products - in particular new diabetes therapies - has become paramount in the face of the ever-growing role of the payer and government sectors in the marketplace. Specifically, the cost of diabetes therapies necessitates that payers are not only well educated in the benefits of the therapies but also how the products are different from existing treatments. This Best Practices, LLC study delivers benchmarks around timing of education tactics for payers and identifies the most important edcation activities for payers. Additionally, this study contains qualitative insights from industry executives regarding methods for effectively communicating with payers. Executives can use this research to compare their strategies and tactics with those of leading organizations.

Key Topics

Summary of Key Insights, Findings and Lessons Learned

Research Participants, Launch Experience, and Therapeutic Area Demographics

Post-Approval Early Access Programs: Getting to First Reimbursed Prescription Quickly

Payer Education Starts Early: Focus on Cost and Outcomes

Voices From the Field: Best Practices, Lessons Learned & Pitfalls

Future Trends & Issues

Sample Key Metrics

Timing of Education Activities for Payers and Government Entities

Top Five Education Activities for Payers and Government Entities

Mix of Market Education Investment

Sample Key Findings

Winning Payers On Board: Commence work earlier than in past to win payers, who are increasingly important to market entry in diabetes. Focus on cost and health outcomes. Understand payer needs and engineer them increasingly into clinical trials.

Methodology

Research was conducted through surveys and interviews. Research participants included 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies. Diabetes/Cardiovascular research participants included 11 executives and managers at 11 different industry leading companies. Interviewed nine selected participants.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.